Imagen de Portada

Technical note: Quantifying radionuclide residues in hospital wastewater: A case study on [131I]I and [177mLu]Lu/[177Lu]Lu

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Dennis Kupitz, Eric Einspänner, Heiko Wissel, Martin Volk, Alexander Hohn, Michael C. Kreissl, Oliver S. Grosser
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Medical Physics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hemodialysis‐associated radioactive waste management in [ 131 I]I and [ 177 Lu]Lu radionuclide therapy
por: Dennis Kupitz, et al.
Publicado: (2025)

Validation of the collapsed‐cone superposition for whole‐body patient‐specific dosimetry in [177Lu]Lu‐PSMA‐617 radionuclide therapy
por: Aya Terro, et al.
Publicado: (2025)

Revisiting the segmentation threshold for Lu‐177 SPECT
por: Yibin Liu, et al.
Publicado: (2026)

Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^{177}{\rm Lu}$‐based radio‐pharmaceutical therapy
por: Siju C. George, et al.
Publicado: (2024)

In silico assessment of cellular damage from Lu‐177, Ac‐225, and Pb‐212 therapeutic radionuclides
por: Konstantinos P. Chatzipapas, et al.
Publicado: (2025)

Direct estimation of activity concentration in regional voxels with application to 177 Lu peptide receptor radionuclide therapy
por: Johan Gustafsson, et al.
Publicado: (2026)

Artifact‐free partial volume correction for 177 Lu‐PSMA SPECT
por: Yibin Liu, et al.
Publicado: (2025)

Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc‐99m, F‐18, I‐131, and Lu‐177
por: Michael Oumano, et al.
Publicado: (2025)

Systematic review and meta‐analysis of the efficacy and safety of [ 177 Lu ]Lu‐edotreotide ([ 177 Lu ]Lu‐ DOTATOC ) for the treatment of neuroendocrine tumors
por: Richard P. Baum, et al.
Publicado: (2025)

Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT)
por: Elmira Yazdani, et al.
Publicado: (2025)

Multicenter Comparison of Radionuclide Calibrators and SPECT/CT Protocols for Quantitative 177Lu Imaging in Clinical Practice
por: Claeys, Wies, et al.
Publicado: (2026)

Conventional versus Monte Carlo SPECT reconstruction of Lu‐177: Toward reduced bias and variance in quantitative imaging
por: Lucas A. Polson, et al.
Publicado: (2025)

Novel Application of Lutetium‐177‐Prostate Specific Membrane Antigen (LuPSMA) Radioligand Therapy for Metastatic Synovial Sarcoma
por: Rhiannon S. McBean, et al.
Publicado: (2025)

Framework to calculate 225 Ac, 177 Lu, and 161 Tb radiation dose and biological effect in metastatic castration‐resistant prostate cancer treatment
por: Shahin Ghaseminejad, et al.
Publicado: (2025)

Compact Accelerator-Based Production of Carrier-free $^{177}$Lu From 18 MeV $D^+$ on [$^{176}$Yb]Yb$_2$O$_3$
por: Morris, Austin A., et al.
Publicado: (2025)

Stability in production and transport of 177Lu labeled PSMA
por: Cristian Antonio Wieczorek Villas Boas
Publicado: (2021)

Feasibility of determining external beam radiotherapy dose using LuSy dosimeter
por: Janatul Madinah Wahabi, et al.
Publicado: (2024)

177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
por: Mathilde Ponchelle, et al.
Publicado: (2024)

Wimb Lu
Publicado: (2013)

Formulation of patient dose of [177Lu]Lu‐Trastuzumab using in‐house developed freeze‐dried kit: A path forward for clinical translation
por: Jeyachitra Amirdhanayagam, et al.
Publicado: (2024)

[natY/90Y]Yttrium and [natLu/177Lu]Lutetium Complexation by Rigid H4OCTAPA Derivatives. Effect of Ligand Topology
por: Fátima Lucio‐Martínez, et al.
Publicado: (2025)

Doratomantispinae Lu 2020
por: Li, Hongyu, et al.
Publicado: (2022)

Terapia con [177 Lu – Dota0 – Tyr 3]-Octreotate (177 Lu- Dotatate) en pacientes con tumores avanzados de origen neuroendocrino: experiencia inicial y resultados preliminares
por: Víctor Marín-Oyaga
Publicado: (2017)

Doratomantispa ares Lu 2020
por: Li, Hongyu, et al.
Publicado: (2022)

Lu's conjecture for minimal surfaces
por: Ding, Weiran, et al.
Publicado: (2026)

No More DeLuLu: Physics-Inspired Kernel Networks for Geometrically-Grounded Neural Computation
por: Bouhsine, Taha
Publicado: (2026)

Automated radiolabeling and handling of 177Lu‐ and 225Ac‐PSMA‐617 using a robotic pipettor
por: Shin Hye Ahn, et al.
Publicado: (2024)

Visualization of the Spiral Ganglion Neuron in Vivo Using a Novel 177 Lu Nuclear Molecule Label
por: Chenyang Kong, et al.
Publicado: (2025)

A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells
por: Myrna Luna-Gutiérrez
Publicado: (2013)

Linear map-making with LuSEE-Night
por: Camacho, Hugo, et al.
Publicado: (2025)

Para que m s gente entienda China / Lu Rucai
por: Lu Rucai
Publicado: (2010)

Radiolabelled 177Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers
por: Patrick A. Cieslik, et al.
Publicado: (2024)

Fe/Cu Bimetallic Nanozyme Co‐Assembled with 177Lu and Tanshinone for Quadruple‐Synergistic Tumor‐Specific Therapy
por: Xianyu Zhu, et al.
Publicado: (2024)

Zeeman Degenerate Sideband Cooling in $^{176}$Lu$^+$
por: Qichen, Qin, et al.
Publicado: (2025)

Lin-Lu-Yau Ricci curvature on hypergraphs
por: Tian, Yulu, et al.
Publicado: (2025)

Connectivity versus Lin-Lu-Yau curvature
por: Chen, Kaizhe, et al.
Publicado: (2025)

Low-lying level structures in $^{162}$Lu
por: Susshma, N, et al.
Publicado: (2025)

Superconductivity in amorphous and crystalline Re-Lu films
por: Teknowijoyo, Serafim, et al.
Publicado: (2023)

Anomaly in first-forbidden transitions of $^{176}$Lu
por: Ran, Jing-Wen, et al.
Publicado: (2025)

a¿Eliges luo hun? / Lu Rucai
por: Lu Rucai